Biggest News Aggregation in the World
📰 Jak Knowles News

Jak Knowles News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Jak Knowles. Real-time updates on events, politics, business and more.

Affini-T Therapeutics Completes $175 Million Financing Co-Led by Vida Ventures and Leaps by Bayer to Advance Groundbreaking T Cell Therapies for Solid Tumor Patients with Oncogenic Driver Mutations

Co-founded at Fred Hutchinson Cancer Research Center with Phil Greenberg, M.D., Aude Chapuis, M.D., and Tom Schmitt, Ph.D., and Vida Ventures along with serial entrepreneurs Arjun Goyal, M.D., M.Phil., and Jak Knowles, M.D./ Foundational cell therapy platform builds upon seminal work from co-founders, leveraging a T Cell Receptor (TCR) discovery en
Phil Greenberg Arjun Goyal Aude Chapuis Tom Schmitt Fred Hutchinson Cancer Research Center Vida Ventures

Affini-T Therapeutics, Inc.: Affini-T Therapeutics Completes $175 Million Financing Co-Led by Vida Ventures and Leaps by Bayer to Advance Groundbreaking T Cell Therapies for Solid Tumor Patients with Oncogenic Driver Mutations

Co-founded at Fred Hutchinson Cancer Research Center with Phil Greenberg, M.D., Aude Chapuis, M.D., and Tom Schmitt, Ph.D., and Vida Ventures along with serial entrepreneurs Arjun Goyal, M.D., M.Phil.
United States Fred Hutchinson Cancer Research Center Al Iskandariyah Fred Hutch Aude Chapuis Imke Meyer

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science